English
简体中文
Total: £ 56.28
Published Date: 2025-11-06 | Pages: 135 | Tables: 141 | Pharma & Healthcare
The global N-Formyl Peptide market is projected to grow from US$ 27.1 million in 2024 to US$ 43.9 million by 2031, at a CAGR of 7.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
N-formyl peptides refer to a type of peptide containing an N-formyl group (formyl group bonded to a nitrogen atom). In biochemistry, N-formyl peptide usually refers to a peptide chain with a formyl group at the N-terminus. This modification is usually achieved through an enzymatic formylation reaction. N-formylation modification may affect the stability, hydrophilicity, interactivity and other properties of the peptide, thereby regulating the biological function of the peptide.
As an important branch in the field of biotechnology and chemistry, the N-formyl peptide market has shown steady growth in recent years. With the rapid development of biomedical technology, the demand for N-formyl peptides is increasing year by year. Especially in the fields of new drug research and development, biotherapy and diagnostic reagents, N-formyl peptides are in great demand as important active ingredients or research tools. In addition, in addition to the traditional pharmaceutical field, the application of N-formyl peptides in agriculture, chemical industry, food and other fields is also gradually expanding. For example, in the agricultural field, N-formyl peptides can be used as biopesticides or plant growth regulators; in the chemical industry, they can be used to synthesize new functional materials. In summary, the N-formyl peptide market is currently in a stage of stable growth and has broad development prospects.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global N-Formyl Peptide market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Sigma-Aldrich
Merck
Thermo Fisher Scientific
TCI
Santa Cruz Biotechnology
Bachem
Peptide Institute
Enzo Life Sciences
AnaSpec
GL Biochem
Segment by Type
Short Chain
Long Chain
Hybrid
Segment by Application
Medicine
Agriculture
Chemical Industry
Other
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the N-Formyl Peptide study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Introduction to N-Formyl Peptide: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global N-Formyl Peptide Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Short Chain
1.2.3 Long Chain
1.2.4 Hybrid
1.3 Market Segmentation by Application
1.3.1 Global N-Formyl Peptide Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Medicine
1.3.3 Agriculture
1.3.4 Chemical Industry
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global N-Formyl Peptide Revenue Estimates and Forecasts 2020-2031
2.2 Global N-Formyl Peptide Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global N-Formyl Peptide Sales Estimates and Forecasts 2020-2031
2.4 Global N-Formyl Peptide Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global N-Formyl Peptide Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global N-Formyl Peptide Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Short Chain Market Size by Manufacturers
3.5.2 Long Chain Market Size by Manufacturers
3.5.3 Hybrid Market Size by Manufacturers
3.6 Global N-Formyl Peptide Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global N-Formyl Peptide Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global N-Formyl Peptide Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global N-Formyl Peptide Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global N-Formyl Peptide Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America N-Formyl Peptide Sales and Revenue by Type (2020-2031)
6.4 North America N-Formyl Peptide Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America N-Formyl Peptide Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe N-Formyl Peptide Sales and Revenue by Type (2020-2031)
7.4 Europe N-Formyl Peptide Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe N-Formyl Peptide Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific N-Formyl Peptide Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific N-Formyl Peptide Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific N-Formyl Peptide Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America N-Formyl Peptide Sales and Revenue by Type (2020-2031)
9.4 Central and South America N-Formyl Peptide Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America N-Formyl Peptide Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa N-Formyl Peptide Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa N-Formyl Peptide Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa N-Formyl Peptide Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Sigma-Aldrich
11.1.1 Sigma-Aldrich Corporation Information
11.1.2 Sigma-Aldrich Business Overview
11.1.3 Sigma-Aldrich N-Formyl Peptide Product Models, Descriptions and Specifications
11.1.4 Sigma-Aldrich N-Formyl Peptide Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Sigma-Aldrich N-Formyl Peptide Sales by Product in 2024
11.1.6 Sigma-Aldrich N-Formyl Peptide Sales by Application in 2024
11.1.7 Sigma-Aldrich N-Formyl Peptide Sales by Geographic Area in 2024
11.1.8 Sigma-Aldrich N-Formyl Peptide SWOT Analysis
11.1.9 Sigma-Aldrich Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Business Overview
11.2.3 Merck N-Formyl Peptide Product Models, Descriptions and Specifications
11.2.4 Merck N-Formyl Peptide Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Merck N-Formyl Peptide Sales by Product in 2024
11.2.6 Merck N-Formyl Peptide Sales by Application in 2024
11.2.7 Merck N-Formyl Peptide Sales by Geographic Area in 2024
11.2.8 Merck N-Formyl Peptide SWOT Analysis
11.2.9 Merck Recent Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Corporation Information
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific N-Formyl Peptide Product Models, Descriptions and Specifications
11.3.4 Thermo Fisher Scientific N-Formyl Peptide Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Thermo Fisher Scientific N-Formyl Peptide Sales by Product in 2024
11.3.6 Thermo Fisher Scientific N-Formyl Peptide Sales by Application in 2024
11.3.7 Thermo Fisher Scientific N-Formyl Peptide Sales by Geographic Area in 2024
11.3.8 Thermo Fisher Scientific N-Formyl Peptide SWOT Analysis
11.3.9 Thermo Fisher Scientific Recent Developments
11.4 TCI
11.4.1 TCI Corporation Information
11.4.2 TCI Business Overview
11.4.3 TCI N-Formyl Peptide Product Models, Descriptions and Specifications
11.4.4 TCI N-Formyl Peptide Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 TCI N-Formyl Peptide Sales by Product in 2024
11.4.6 TCI N-Formyl Peptide Sales by Application in 2024
11.4.7 TCI N-Formyl Peptide Sales by Geographic Area in 2024
11.4.8 TCI N-Formyl Peptide SWOT Analysis
11.4.9 TCI Recent Developments
11.5 Santa Cruz Biotechnology
11.5.1 Santa Cruz Biotechnology Corporation Information
11.5.2 Santa Cruz Biotechnology Business Overview
11.5.3 Santa Cruz Biotechnology N-Formyl Peptide Product Models, Descriptions and Specifications
11.5.4 Santa Cruz Biotechnology N-Formyl Peptide Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Santa Cruz Biotechnology N-Formyl Peptide Sales by Product in 2024
11.5.6 Santa Cruz Biotechnology N-Formyl Peptide Sales by Application in 2024
11.5.7 Santa Cruz Biotechnology N-Formyl Peptide Sales by Geographic Area in 2024
11.5.8 Santa Cruz Biotechnology N-Formyl Peptide SWOT Analysis
11.5.9 Santa Cruz Biotechnology Recent Developments
11.6 Bachem
11.6.1 Bachem Corporation Information
11.6.2 Bachem Business Overview
11.6.3 Bachem N-Formyl Peptide Product Models, Descriptions and Specifications
11.6.4 Bachem N-Formyl Peptide Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Bachem Recent Developments
11.7 Peptide Institute
11.7.1 Peptide Institute Corporation Information
11.7.2 Peptide Institute Business Overview
11.7.3 Peptide Institute N-Formyl Peptide Product Models, Descriptions and Specifications
11.7.4 Peptide Institute N-Formyl Peptide Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Peptide Institute Recent Developments
11.8 Enzo Life Sciences
11.8.1 Enzo Life Sciences Corporation Information
11.8.2 Enzo Life Sciences Business Overview
11.8.3 Enzo Life Sciences N-Formyl Peptide Product Models, Descriptions and Specifications
11.8.4 Enzo Life Sciences N-Formyl Peptide Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Enzo Life Sciences Recent Developments
11.9 AnaSpec
11.9.1 AnaSpec Corporation Information
11.9.2 AnaSpec Business Overview
11.9.3 AnaSpec N-Formyl Peptide Product Models, Descriptions and Specifications
11.9.4 AnaSpec N-Formyl Peptide Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 AnaSpec Recent Developments
11.10 GL Biochem
11.10.1 GL Biochem Corporation Information
11.10.2 GL Biochem Business Overview
11.10.3 GL Biochem N-Formyl Peptide Product Models, Descriptions and Specifications
11.10.4 GL Biochem N-Formyl Peptide Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 GL Biochem Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 N-Formyl Peptide Industry Chain
12.2 N-Formyl Peptide Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 N-Formyl Peptide Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 N-Formyl Peptide Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 N-Formyl Peptide Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global N-Formyl Peptide Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global N-Formyl Peptide Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global N-Formyl Peptide Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global N-Formyl Peptide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global N-Formyl Peptide Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global N-Formyl Peptide Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global N-Formyl Peptide Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (kg)
Table 7. Global N-Formyl Peptide Sales by Region (2020-2025) & (kg)
Table 8. Global N-Formyl Peptide Sales by Region (2026-2031) & (kg)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global N-Formyl Peptide Sales by Manufacturers (2020-2025) & (kg)
Table 11. Global N-Formyl Peptide Sales Share by Manufacturers (2020-2025)
Table 12. Global N-Formyl Peptide Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global N-Formyl Peptide Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global N-Formyl Peptide by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in N-Formyl Peptide as of 2024)
Table 16. Global N-Formyl Peptide Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global N-Formyl Peptide Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/g)
Table 18. Key Manufacturers N-Formyl Peptide Manufacturing Base and Headquarters
Table 19. Global N-Formyl Peptide Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global N-Formyl Peptide Sales by Type (2020-2025) & (kg)
Table 23. Global N-Formyl Peptide Sales by Type (2026-2031) & (kg)
Table 24. Global N-Formyl Peptide Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global N-Formyl Peptide Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global N-Formyl Peptide ASP by Type (2020-2031) & (US$/g)
Table 27. Technical Specifications by Key Product Type
Table 28. Global N-Formyl Peptide Sales by Application (2020-2025) & (kg)
Table 29. Global N-Formyl Peptide Sales by Application (2026-2031) & (kg)
Table 30. N-Formyl Peptide High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global N-Formyl Peptide Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global N-Formyl Peptide Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global N-Formyl Peptide ASP by Application (2020-2031) & (US$/g)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America N-Formyl Peptide Growth Accelerators and Market Barriers
Table 37. North America N-Formyl Peptide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America N-Formyl Peptide Sales (kg) by Country (2020 VS 2024 VS 2031)
Table 39. Europe N-Formyl Peptide Growth Accelerators and Market Barriers
Table 40. Europe N-Formyl Peptide Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe N-Formyl Peptide Sales (kg) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific N-Formyl Peptide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific N-Formyl Peptide Sales (kg) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific N-Formyl Peptide Growth Accelerators and Market Barriers
Table 45. Southeast Asia N-Formyl Peptide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America N-Formyl Peptide Investment Opportunities and Key Challenges
Table 47. Central and South America N-Formyl Peptide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa N-Formyl Peptide Investment Opportunities and Key Challenges
Table 49. Middle East and Africa N-Formyl Peptide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Sigma-Aldrich Corporation Information
Table 51. Sigma-Aldrich Description and Major Businesses
Table 52. Sigma-Aldrich Product Models, Descriptions and Specifications
Table 53. Sigma-Aldrich Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 54. Sigma-Aldrich Sales Value Proportion by Product in 2024
Table 55. Sigma-Aldrich Sales Value Proportion by Application in 2024
Table 56. Sigma-Aldrich Sales Value Proportion by Geographic Area in 2024
Table 57. Sigma-Aldrich N-Formyl Peptide SWOT Analysis
Table 58. Sigma-Aldrich Recent Developments
Table 59. Merck Corporation Information
Table 60. Merck Description and Major Businesses
Table 61. Merck Product Models, Descriptions and Specifications
Table 62. Merck Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 63. Merck Sales Value Proportion by Product in 2024
Table 64. Merck Sales Value Proportion by Application in 2024
Table 65. Merck Sales Value Proportion by Geographic Area in 2024
Table 66. Merck N-Formyl Peptide SWOT Analysis
Table 67. Merck Recent Developments
Table 68. Thermo Fisher Scientific Corporation Information
Table 69. Thermo Fisher Scientific Description and Major Businesses
Table 70. Thermo Fisher Scientific Product Models, Descriptions and Specifications
Table 71. Thermo Fisher Scientific Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 72. Thermo Fisher Scientific Sales Value Proportion by Product in 2024
Table 73. Thermo Fisher Scientific Sales Value Proportion by Application in 2024
Table 74. Thermo Fisher Scientific Sales Value Proportion by Geographic Area in 2024
Table 75. Thermo Fisher Scientific N-Formyl Peptide SWOT Analysis
Table 76. Thermo Fisher Scientific Recent Developments
Table 77. TCI Corporation Information
Table 78. TCI Description and Major Businesses
Table 79. TCI Product Models, Descriptions and Specifications
Table 80. TCI Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 81. TCI Sales Value Proportion by Product in 2024
Table 82. TCI Sales Value Proportion by Application in 2024
Table 83. TCI Sales Value Proportion by Geographic Area in 2024
Table 84. TCI N-Formyl Peptide SWOT Analysis
Table 85. TCI Recent Developments
Table 86. Santa Cruz Biotechnology Corporation Information
Table 87. Santa Cruz Biotechnology Description and Major Businesses
Table 88. Santa Cruz Biotechnology Product Models, Descriptions and Specifications
Table 89. Santa Cruz Biotechnology Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 90. Santa Cruz Biotechnology Sales Value Proportion by Product in 2024
Table 91. Santa Cruz Biotechnology Sales Value Proportion by Application in 2024
Table 92. Santa Cruz Biotechnology Sales Value Proportion by Geographic Area in 2024
Table 93. Santa Cruz Biotechnology N-Formyl Peptide SWOT Analysis
Table 94. Santa Cruz Biotechnology Recent Developments
Table 95. Bachem Corporation Information
Table 96. Bachem Description and Major Businesses
Table 97. Bachem Product Models, Descriptions and Specifications
Table 98. Bachem Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 99. Bachem Recent Developments
Table 100. Peptide Institute Corporation Information
Table 101. Peptide Institute Description and Major Businesses
Table 102. Peptide Institute Product Models, Descriptions and Specifications
Table 103. Peptide Institute Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 104. Peptide Institute Recent Developments
Table 105. Enzo Life Sciences Corporation Information
Table 106. Enzo Life Sciences Description and Major Businesses
Table 107. Enzo Life Sciences Product Models, Descriptions and Specifications
Table 108. Enzo Life Sciences Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 109. Enzo Life Sciences Recent Developments
Table 110. AnaSpec Corporation Information
Table 111. AnaSpec Description and Major Businesses
Table 112. AnaSpec Product Models, Descriptions and Specifications
Table 113. AnaSpec Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 114. AnaSpec Recent Developments
Table 115. GL Biochem Corporation Information
Table 116. GL Biochem Description and Major Businesses
Table 117. GL Biochem Product Models, Descriptions and Specifications
Table 118. GL Biochem Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 119. GL Biochem Recent Developments
Table 120. Key Raw Materials Distribution
Table 121. Raw Materials Key Suppliers
Table 122. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 123. Milestones in Production Technology Evolution
Table 124. Distributors List
Table 125. Market Trends and Market Evolution
Table 126. Market Drivers and Opportunities
Table 127. Market Challenges, Risks, and Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. N-Formyl Peptide Product Picture
Figure 2. Global N-Formyl Peptide Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Short Chain Product Picture
Figure 4. Long Chain Product Picture
Figure 5. Hybrid Product Picture
Figure 6. Global N-Formyl Peptide Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Medicine
Figure 8. Agriculture
Figure 9. Chemical Industry
Figure 10. Other
Figure 11. N-Formyl Peptide Report Years Considered
Figure 12. Global N-Formyl Peptide Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global N-Formyl Peptide Revenue (2020-2031) & (US$ Million)
Figure 14. Global N-Formyl Peptide Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global N-Formyl Peptide Revenue Market Share by Region (2020-2031)
Figure 16. Global N-Formyl Peptide Sales (2020-2031) & (kg)
Figure 17. Global N-Formyl Peptide Sales (CAGR) by Region (2020-2031) (kg)
Figure 18. Global N-Formyl Peptide Sales Market Share by Region (2020-2031)
Figure 19. Top 5 and Top 10 Manufacturers N-Formyl Peptide Sales Volume Market Share in 2024
Figure 20. Global N-Formyl Peptide Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. Short Chain Revenue Market Share by Manufacturer in 2024
Figure 23. Long Chain Revenue Market Share by Manufacturer in 2024
Figure 24. Hybrid Revenue Market Share by Manufacturer in 2024
Figure 25. Global N-Formyl Peptide Sales Market Share by Type (2020-2031)
Figure 26. Global N-Formyl Peptide Revenue Market Share by Type (2020-2031)
Figure 27. Global N-Formyl Peptide Sales Market Share by Application (2020-2031)
Figure 28. Global N-Formyl Peptide Revenue Market Share by Application (2020-2031)
Figure 29. North America N-Formyl Peptide Sales YoY (2020-2031) & (kg)
Figure 30. North America N-Formyl Peptide Revenue YoY (2020-2031) & (US$ Million)
Figure 31. North America Top 5 Manufacturers N-Formyl Peptide Sales Revenue (US$ Million) in 2024
Figure 32. North America N-Formyl Peptide Sales Volume (kg) by Type (2020- 2031)
Figure 33. North America N-Formyl Peptide Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 34. North America N-Formyl Peptide Sales Volume (kg) by Application (2020-2031)
Figure 35. North America N-Formyl Peptide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 36. US N-Formyl Peptide Revenue (2020-2031) & (US$ Million)
Figure 37. Canada N-Formyl Peptide Revenue (2020-2031) & (US$ Million)
Figure 38. Mexico N-Formyl Peptide Revenue (2020-2031) & (US$ Million)
Figure 39. Europe N-Formyl Peptide Sales YoY (2020-2031) & (kg)
Figure 40. Europe N-Formyl Peptide Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Europe Top 5 Manufacturers N-Formyl Peptide Sales Revenue (US$ Million) in 2024
Figure 42. Europe N-Formyl Peptide Sales Volume (kg) by Type (2020-2031)
Figure 43. Europe N-Formyl Peptide Sales Revenue (US$ Million) by Type (2020-2031)
Figure 44. Europe N-Formyl Peptide Sales Volume (kg) by Application (2020-2031)
Figure 45. Europe N-Formyl Peptide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 46. Germany N-Formyl Peptide Revenue (2020-2031) & (US$ Million)
Figure 47. France N-Formyl Peptide Revenue (2020-2031) & (US$ Million)
Figure 48. U.K. N-Formyl Peptide Revenue (2020-2031) & (US$ Million)
Figure 49. Italy N-Formyl Peptide Revenue (2020-2031) & (US$ Million)
Figure 50. Russia N-Formyl Peptide Revenue (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific N-Formyl Peptide Sales YoY (2020-2031) & (kg)
Figure 52. Asia-Pacific N-Formyl Peptide Revenue YoY (2020-2031) & (US$ Million)
Figure 53. Asia-Pacific Top 8 Manufacturers N-Formyl Peptide Sales Revenue (US$ Million) in 2024
Figure 54. Asia-Pacific N-Formyl Peptide Sales Volume (kg) by Type (2020- 2031)
Figure 55. Asia-Pacific N-Formyl Peptide Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 56. Asia-Pacific N-Formyl Peptide Sales Volume (kg) by Application (2020-2031)
Figure 57. Asia-Pacific N-Formyl Peptide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 58. Indonesia N-Formyl Peptide Revenue (2020-2031) & (US$ Million)
Figure 59. Japan N-Formyl Peptide Revenue (2020-2031) & (US$ Million)
Figure 60. South Korea N-Formyl Peptide Revenue (2020-2031) & (US$ Million)
Figure 61. China Taiwan N-Formyl Peptide Revenue (2020-2031) & (US$ Million)
Figure 62. India N-Formyl Peptide Revenue (2020-2031) & (US$ Million)
Figure 63. Central and South America N-Formyl Peptide Sales YoY (2020-2031) & (kg)
Figure 64. Central and South America N-Formyl Peptide Revenue YoY (2020-2031) & (US$ Million)
Figure 65. Central and South America Top 5 Manufacturers N-Formyl Peptide Sales Revenue (US$ Million) in 2024
Figure 66. Central and South America N-Formyl Peptide Sales Volume (kg) by Type (2021-2031)
Figure 67. Central and South America N-Formyl Peptide Sales Revenue (US$ Million) by Type (2020-2031)
Figure 68. Central and South America N-Formyl Peptide Sales Volume (kg) by Application (2020-2031)
Figure 69. Central and South America N-Formyl Peptide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 70. Brazil N-Formyl Peptide Revenue (2020-2025) & (US$ Million)
Figure 71. Argentina N-Formyl Peptide Revenue (2020-2025) & (US$ Million)
Figure 72. Middle East, and Africa N-Formyl Peptide Sales YoY (2020-2031) & (kg)
Figure 73. Middle East and Africa N-Formyl Peptide Revenue YoY (2020-2031) & (US$ Million)
Figure 74. Middle East and Africa Top 5 Manufacturers N-Formyl Peptide Sales Revenue (US$ Million) in 2024
Figure 75. Middle East and Africa N-Formyl Peptide Sales Volume (kg) by Type (2021-2031)
Figure 76. South America N-Formyl Peptide Sales Revenue (US$ Million) by Type (2020-2031)
Figure 77. Middle East and Africa N-Formyl Peptide Sales Volume (kg) by Application (2020-2031)
Figure 78. Middle East and Africa N-Formyl Peptide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 79. GCC Countries N-Formyl Peptide Revenue (2020-2025) & (US$ Million)
Figure 80. Turkey N-Formyl Peptide Revenue (2020-2025) & (US$ Million)
Figure 81. Egypt N-Formyl Peptide Revenue (2020-2025) & (US$ Million)
Figure 82. South Africa N-Formyl Peptide Revenue (2020-2025) & (US$ Million)
Figure 83. N-Formyl Peptide Industry Chain Mapping
Figure 84. Regional N-Formyl Peptide Manufacturing Base Distribution (%)
Figure 85. Global N-Formyl Peptide Production Market Share by Region (2020-2031)
Figure 86. N-Formyl Peptide Production Process
Figure 87. Regional N-Formyl Peptide Production Cost Structure
Figure 88. Channels of Distribution (Direct Vs Distribution)
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
